Our Research
- Prostate/Bladder Cancer Biobank and Clinical Database
- Clinical Trials in NMIBC and High Risk Prostate Cancer
- CRISPR Screen of Surface Targets in Bladder and Prostate
- Drug Resistance Mechanisms in vitro
- PET-based imaging in bladder and prostate cancers
Our People
Research Team and Lab Collaborators
Post-doc
Project(s)
- STEAP1 CRISPR screen (prostate)
- NECTIN4 CRISPR screen (bladder)
- Prostate cancer biomarkers
MS3 (UCSF)
Project(s)
- Staging impact of PSMA PET imaging
- ArteraAI classifier for BCG response in NMIBC
Senior Specialist
Project(s)
Resistance mechanisms to targeted therapies in vitro models
Mentors and Collaborators
Latest Research
Exploring STEAP1 in Prostate Cancer: From CRISPR Screens to a Neoadjuvant Bispecific Trial
Interview by UroToday with Dr. Carissa Chu
Role of PSMA PET in Surgical Planning, Post-Operative Management
2025 PSMA and Beyond Conference
Presentation by Dr. Carissa Chu
Neoadjuvant Prostate Cancer Clinical Trials: Advancing Care and Science
BIPCR Basic Research in Prostate Cancer
Presentation by Dr. Carissa Chu
Bench to Bedside: Translational Approaches to Studying Drug Resistance in Urothelial Carcinoma
UCSF Urology Grand Rounds
Presentation by Dr. Carissa Chu
Funding
UCSF Paul Calabresi K12 Career Development Program in Clinical Oncology (K12CA260225)
Prostate Cancer Foundation Young Investigator Award
Benioff Initiative for Prostate Cancer Research
NIH SPORE Career Enhancement Program
AACR Bladder Cancer Innovation Grant
UCSF Bladder Cancer Research Hub Award
Stephen & Faith Brown Endowed Professorship
Boston Scientific Research Grant
Featured Work













